Neuromodulation Devices Market, By Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices), By Application (Pain Management, Neu
Description
Neuromodulation Devices Market, By Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices), By Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.
Restraints of the Global Neuromodulation Devices Market
Side effects and risks associated with the use of neuromodulation devices are expected to hinder growth of the global neuromodulation devices market.
Key features of the study:
This report provides in-depth analysis of the global neuromodulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global neuromodulation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Axonics Modulation Technologies, Inc., ShiraTronics, Inc., Bioness, Inc., LivaNova, Neuronetics, Inc., Medtronic plc, St. Jude Medical, Boston Scientific Corporation, Cyberonics, Nevro, Integer Holdings Corporation, and Uroplasty
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Neuromodulation Devices Market, By Device Type:
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
Global Neuromodulation Devices Market, By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
Global Neuromodulation Devices Market, By End User:
Hospitals
Specialty Clinics
Ambulatory Centers
Others
Global Neuromodulation Devices Market, By Geography:
North America
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
U.S.
Canada
Europe
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Axonics Modulation Technologies, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
ShiraTronics, Inc.
Bioness, Inc.
LivaNova
Neuronetics, Inc.
Medtronic plc
St. Jude Medical
Boston Scientific Corporation
Cyberonics
Nevro
Integer Holdings Corporation
Uroplasty
“*” marked represents similar segmentation in other categories in the respective section.
Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.
Restraints of the Global Neuromodulation Devices Market
Side effects and risks associated with the use of neuromodulation devices are expected to hinder growth of the global neuromodulation devices market.
Key features of the study:
This report provides in-depth analysis of the global neuromodulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global neuromodulation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Axonics Modulation Technologies, Inc., ShiraTronics, Inc., Bioness, Inc., LivaNova, Neuronetics, Inc., Medtronic plc, St. Jude Medical, Boston Scientific Corporation, Cyberonics, Nevro, Integer Holdings Corporation, and Uroplasty
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Neuromodulation Devices Market, By Device Type:
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
Global Neuromodulation Devices Market, By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
Global Neuromodulation Devices Market, By End User:
Hospitals
Specialty Clinics
Ambulatory Centers
Others
Global Neuromodulation Devices Market, By Geography:
North America
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
U.S.
Canada
Europe
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Device Type
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation Devices
Vagus Nerve Stimulation Devices
Gastric Electric Stimulation Devices
By Application:
Pain Management
Neurological and Movement Disorder Management
Musculoskeletal Disorder Management
Metabolism & GIT Management
Incontinence Management
Others
By End User
Hospitals
Specialty Clinics
Ambulatory Centers
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Axonics Modulation Technologies, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
ShiraTronics, Inc.
Bioness, Inc.
LivaNova
Neuronetics, Inc.
Medtronic plc
St. Jude Medical
Boston Scientific Corporation
Cyberonics
Nevro
Integer Holdings Corporation
Uroplasty
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
183 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Device Type
- Market Snippet, By Application
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Technological Advancement
- Regulatory Scenario
- 4. Global Neuromodulation Devices Market, By Device Type, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Spinal Cord Stimulation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Deep Brain Stimulation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Sacral Nerve Stimulation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Vagus Nerve Stimulation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Gastric Electric Stimulation Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- 5. Global Neuromodulation Devices Market, By Application, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Neurological and Movement Disorder Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Musculoskeletal Disorder Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Metabolism & GIT Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Incontinence Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. Global Neuromodulation Devices Market, By End User, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ambulatory Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 7. Global Neuromodulation Devices Market, By Regions, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- 8. Competitive Landscape
- Company Profiles
- Axonics Modulation Technologies, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ShiraTronics, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioness, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neuronetics, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- St. Jude Medical
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyberonics
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nevro
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integer Holdings Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Uroplasty
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 37 market data tables and 25 figures on “Neuromodulation Devices Market – Global forecast to 2028.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

